Thomas F Murray Selected Research

hoiamide A

8/2009

Hoiamide a, a sodium channel activator of unusual architecture from a consortium of two papua new Guinea cyanobacteria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas F Murray Research Topics

Disease

3	Substance-Related Disorders (Drug Abuse) 01/2021 - 01/2018
2	Mood Disorders (Mood Disorder) 01/2021 - 01/2018
2	Neoplasms (Cancer) 08/2009 - 04/2006
1	Ischemic Stroke 07/2020
1	Infarction (Infarctions) 07/2020
1	Stroke (Strokes) 07/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Necrosis 02/2015
1	Endotoxemia 06/2008
1	Breast Neoplasms (Breast Cancer) 04/2006
1	Neuroblastoma 01/2005
1	Sepsis (Septicemia) 11/2002
1	Bacterial Infections (Bacterial Infection) 10/2002

Drug/Important Bio-Agent (IBA)

2	Voltage-Gated Sodium ChannelsIBA 08/2009 - 01/2005
2	Lipid AIBA 06/2008 - 11/2002
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2006 - 01/2005
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2021
1	Ptychodiscus brevis T2 toxinIBA 07/2020
1	brevetoxinIBA 07/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Cocaine (Cocaine HCl)IBA 01/2020
1	CJ 15,208IBA 01/2020
1	Opioid Receptors (Opioid Receptor)IBA 01/2018
1	CalciumIBA 01/2017
1	Calcium Channels (Calcium Channel)IBA 01/2017
1	Caspase 3 (Caspase-3)IBA 02/2015
1	hoiamide AIBA 08/2009
1	SodiumIBA 08/2009
1	E5564IBA 06/2008
1	lophocladine AIBA 04/2006
1	delta Opioid Receptors (delta Opioid Receptor)IBA 04/2006
1	lophocladine BIBA 04/2006
1	NeurotoxinsIBA 01/2005
1	CytokinesIBA 10/2002
1	LipopolysaccharidesIBA 10/2002